Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer
Authors
Coe, FayeMisra, Vivek
McCabe, Yamini
Adderley, Helen
Woodhouse, Laura
Ayub, Zaheen
Wang, Xin
Howell, Sacha J
Ekholm, Maria
Affiliation
Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2021
Metadata
Show full item recordCitation
Coe F, Misra V, McCabe Y, Adderley H, Woodhouse L, Ayub Z, et al. Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021.Journal
Breast Cancer Research and TreatmentDOI
10.1007/s10549-021-06438-7PubMed ID
34843027Type
Articleae974a485f413a2113503eed53cd6c53
10.1007/s10549-021-06438-7
Scopus Count
Collections
Related articles
- Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer.
- Authors: Chabot I, Zhao Q, Su Y
- Issue date: 2020 Dec
- Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study.
- Authors: Ni M, Zhou L, Lu Y, Guo D, Li X, Li L, Zhang L, Chen M, Zhang L, Xu F, Yuan Z, Wang S, Shi Y, Yang A, An X
- Issue date: 2024 Sep 30
- Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States.
- Authors: Mougalian SS, Kish JK, Zhang J, Liassou D, Feinberg BA
- Issue date: 2021 May
- Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
- Authors: Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A
- Issue date: 2019 Sep-Oct
- Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
- Authors: Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A
- Issue date: 2020 Mar-Apr